pharmaceutical investing OncoMed Announces First Quarter 2018 Financial Results and Operational Highlights
pharmaceutical investing OncoMed Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights
pharmaceutical investing DelMar Pharmaceuticals Presents Data Supporting VAL-083 as a Component of Combination Chemotherapy Regimens for the Treatment of Solid Tumors including Brain and Ovarian Cancer
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
Brixton Metals Announces Closing of Option Agreement to Acquire a 100% Interest in the Silver Focused Silvergruvan Project in Sweden
